PL375893A1 - Treatment of chronic heart failure - Google Patents
Treatment of chronic heart failureInfo
- Publication number
- PL375893A1 PL375893A1 PL03375893A PL37589303A PL375893A1 PL 375893 A1 PL375893 A1 PL 375893A1 PL 03375893 A PL03375893 A PL 03375893A PL 37589303 A PL37589303 A PL 37589303A PL 375893 A1 PL375893 A1 PL 375893A1
- Authority
- PL
- Poland
- Prior art keywords
- treatment
- heart failure
- chronic heart
- chronic
- failure
- Prior art date
Links
- 206010007558 Cardiac failure chronic Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/325,420 US20040122067A1 (en) | 2002-12-20 | 2002-12-20 | Treatment of chronic heart failure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL375893A1 true PL375893A1 (en) | 2005-12-12 |
Family
ID=32593758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL03375893A PL375893A1 (en) | 2002-12-20 | 2003-12-11 | Treatment of chronic heart failure |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20040122067A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1581308A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2006514051A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2506719A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA05006628A (cg-RX-API-DMAC7.html) |
| PL (1) | PL375893A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2004060489A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005027887A2 (en) * | 2003-09-17 | 2005-03-31 | Cardimone Pharma Corporation | Methods and compositions for improving endothelial function |
| WO2006121995A2 (en) * | 2005-05-09 | 2006-11-16 | Tap Pharmaceutical Products, Inc. | Methods for treating nephrolithiasis |
| CA2669935A1 (en) * | 2006-11-13 | 2008-05-29 | Takeda Pharmaceuticals North America, Inc. | Methods for preserving renal function using xanthine oxidoreductase inhibitors |
| US20090124623A1 (en) * | 2006-11-13 | 2009-05-14 | Christopher Lademacher | Methods for preserving and/or increasing renal function using xanthine oxidoreductase inhibitors |
| RU2009131454A (ru) * | 2007-01-19 | 2011-02-27 | Такеда Фармасьютикалз Норт Америка, Инк. (Us) | Способы предупреждения или уменьшения числа обострений подагры с применением ингибиторов ксантиноксидоредуктазы и противовоспалительных средств |
| US20100311756A1 (en) * | 2009-01-22 | 2010-12-09 | Takeda Pharmaceuticals North America, Inc. | Methods for delaying the progression of at least one of cardiac hypertrophy, cardiac remodeling or left ventricular function or the onset of heart failure in subjects in need of treatment thereof |
| GB0909243D0 (en) * | 2009-05-29 | 2009-07-15 | Univ Dundee | Angina treatment |
| IT1400309B1 (it) | 2010-05-10 | 2013-05-24 | Menarini Int Operations Lu Sa | Associazione di inibitori della xantina ossidasi e calcio antagonisti e loro uso. |
| IT1400609B1 (it) | 2010-05-10 | 2013-06-14 | Menarini Int Operations Lu Sa | Associazione di inibitori della xantina ossidasi e metformina e loro uso. |
| IT1400311B1 (it) | 2010-05-10 | 2013-05-24 | Menarini Int Operations Lu Sa | Associazione di inibitori della xantina ossidasi e antagonisti del recettore dell'angiotensina ii e loro uso. |
| IT1400310B1 (it) | 2010-05-10 | 2013-05-24 | Menarini Int Operations Lu Sa | Associazione di inibitori della xantina ossidasi e statine e loro uso. |
| JP5978216B2 (ja) | 2010-09-10 | 2016-08-24 | タケダ ファーマシューティカルズ ユー.エス.エー. インコーポレイティド | テオフィリンとフェブキソスタットの併用療法のための方法 |
| US20170217948A1 (en) | 2014-07-30 | 2017-08-03 | Teijin Pharma Limited | Xanthine oxidase inhibitor |
| JP6684264B2 (ja) * | 2015-02-17 | 2020-04-22 | 株式会社三和化学研究所 | 心不全の予防又は治療のための医薬 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2073981C (en) * | 1990-11-30 | 2002-01-08 | Shiro Kondo | 2-arylthiazole derivatives and pharmaceutical composition thereof |
| AU1520699A (en) * | 1997-11-07 | 1999-05-31 | Johns Hopkins University, The | Methods for treatment of disorders of cardiac contractility |
| CZ297264B6 (cs) * | 1998-09-09 | 2006-10-11 | Metabasis Therapeutics, Inc. | Nové heteroaromatické inhibitory fruktóza-1,6-bisfosfatázy |
| DE69942009D1 (de) * | 1998-10-15 | 2010-03-25 | Imp Innovations Ltd | Verbindungen für die behandlung von gewichtsverlust |
| EP1212064A2 (en) * | 1999-03-09 | 2002-06-12 | Max-Delbrück-Centrum Für Molekulare Medizin | Use of inhibitors of endotoxin for the treatment of heart failure and of cachexia |
-
2002
- 2002-12-20 US US10/325,420 patent/US20040122067A1/en not_active Abandoned
-
2003
- 2003-12-11 CA CA002506719A patent/CA2506719A1/en not_active Abandoned
- 2003-12-11 EP EP03796950A patent/EP1581308A2/en not_active Withdrawn
- 2003-12-11 JP JP2004565376A patent/JP2006514051A/ja active Pending
- 2003-12-11 MX MXPA05006628A patent/MXPA05006628A/es unknown
- 2003-12-11 PL PL03375893A patent/PL375893A1/xx unknown
- 2003-12-11 WO PCT/US2003/039410 patent/WO2004060489A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA05006628A (es) | 2005-09-30 |
| WO2004060489A3 (en) | 2004-11-25 |
| JP2006514051A (ja) | 2006-04-27 |
| EP1581308A2 (en) | 2005-10-05 |
| CA2506719A1 (en) | 2004-07-22 |
| WO2004060489A2 (en) | 2004-07-22 |
| US20040122067A1 (en) | 2004-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0201850D0 (en) | Therapeutic treatment | |
| GB0216321D0 (en) | Therapeutic treatment | |
| IL218909A0 (en) | Treatment of diabetes | |
| EP1804914A4 (en) | BAROREFLEX ACTIVATION AND HEART RESYNCHRONIZATION FOR THE TREATMENT OF HEART FAILURE | |
| GB0201674D0 (en) | Medical treatment | |
| GB0218879D0 (en) | Medical treatment | |
| GB0223367D0 (en) | Therapeutic treatment | |
| IL164078A0 (en) | Treatment of lung disorder | |
| GB0213869D0 (en) | The treatment of pain | |
| GB0223854D0 (en) | Therapeutic treatment | |
| IL162818A0 (en) | Combination therapy for the treatment of bacterialinfections | |
| AU2002249947A1 (en) | Inhibition of protein-phosphatases for the treatment of heart failure | |
| PT1534296E (pt) | UTILIZAÇÃO DE CILOBRADINA OU DOS SEUS SAIS FARMACEUTICAMENTE ACEITÁVEIS PARA O TRATAMENTO OU PREVENÇÃO DA INSUFICIjNCIA CARDÍACA | |
| GB0210464D0 (en) | Therapeutic treatment | |
| GB0221712D0 (en) | Methods of treatment | |
| EP1474151A4 (en) | METHODS OF TREATING CHRONIC IMMUNE DISEASE | |
| GB2409655B (en) | Treatment of fluids | |
| PL372900A1 (en) | Treatment of metabolic syndrome | |
| AUPS020602A0 (en) | Treatment for heart failure | |
| GB0211515D0 (en) | Blood treatment | |
| AU2003900407A0 (en) | Treatment for heart failure | |
| SI1553950T1 (sl) | Terapevtsko zdravljenje | |
| SI1408977T1 (sl) | Kombinacijska terapija za zdravljenje srcne insuficence | |
| GB0223405D0 (en) | Medical treatment | |
| GB0220849D0 (en) | Medical treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DISC | Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications) |